New antibody aims to help lungs heal faster in severe breathing emergencies
Disease control
Ongoing
This study tests a single dose of an experimental antibody called ALT-100 in 15 adults hospitalized with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. The main goal is to check safety and side effects, while also seeing if it re…
Phase: PHASE2 • Sponsor: Aqualung Therapeutics Corp. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC